MedTrace Logo

A New POP (Pelvic Organ Prolapse) Scoring System: Validity and Reliability

NCT06520722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-11-22

No results posted yet for this study

Summary

There is a strong need for a better, simplified and informative applicable classification system that should be used to speak a common descriptive language among health care providers that treat POP.

The aim of our study is to test our proposed system, assess its validity and value in comparison to the widely used current system (POP-Q).

Conditions

  • Pelvic Organ Prolapse
  • Prolapse
  • Prolapse, Vaginal
  • Prolapse Uterus
  • Prolapse; Cervix

Interventions

DIAGNOSTIC_TEST

Prolapse scoring system

A FIXED APCD classification system : A: Associated symptoms: FIXED: F: frequency I: infection X: sex problems E: everted mass(external protrusion of mass from the valva as PV lump sensation ,heaviness,itching and ulceration) D: digitation(patient need to digitate to complete the act of micturation or defecation) APCD: A: Dependent point on anterior wall. P: Dependent point on posterior wall. C: Cuff point either cervix or vault. Distance to hymen in centimeters (minus above or plus below) after pushing the opposite wall during maximal straining D: Dimensions; base diameter of vestibule/ perineal length. The staging system will be interpreted as follows: Normal: A-3 P-3 C-8 D 2/2 Stages: 0: No prolapse. A/P-2 OR C-7 to C-2 A,P or C-1 to +1 A,P or C ˃ +1 X component: (alone or with any stage): Dimension disruption: ˃2 or \<2

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ashraf El-Daly, MD · Cairo University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-07-20
Completion
2024-11-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06520722 on ClinicalTrials.gov